Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD38 | P28907 | 4/20 | 0.80 |
| ▸ | DPP4 | P27487 | 2/20 | 0.80 |
| ▸ | F2 | P00734 | 1/20 | 0.71 |
| ▸ | EGFR | P00533 | 2/20 | 0.50 |
| ▸ | KDR | P35968 | 2/20 | 0.50 |
| ▸ | SNCA | P37840 | 2/20 | 0.50 |
| ▸ | GLO1 | Q04760 | 2/20 | 0.50 |
| ▸ | EP300 | Q09472 | 2/20 | 0.50 |
| ▸ | CREBBP | Q92793 | 2/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.49 |
| ▸ | SLC28A3 | Q9HAS3 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | TYR | P14679 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31213251 | 1.00 | CD38 (0.80) | CD38DPP4F2EGFRKDR | |
| Hydrochloric Acid SCHEMBL29374214 | 1.00 | CD38 (0.80) | CD38DPP4F2EGFRKDR | |
| Hydrochloric Acid SCHEMBL29894453 | 1.00 | CD38 (0.80) | CD38DPP4F2EGFRKDR | |
| SCHEMBL30185877 | 0.99 | CD38 (0.81) | CD38DPP4F2EGFRKDR | |
| SCHEMBL675416 | 0.99 | CD38 (0.81) | CD38DPP4F2EGFRKDR | |
| Hydrochloric Acid SCHEMBL318114 | 0.94 | F2 (0.80) | CD38DPP4F2EPHX2SLC28A3 | |
| Hydrochloric Acid SCHEMBL30437834 | 0.93 | CD38 (0.73) | CD38DPP4F2EPHX2SLC28A3 | |
| Hydrochloric Acid SCHEMBL29894492 | 0.93 | CD38 (0.73) | CD38DPP4F2EPHX2SLC28A3 | |
| SCHEMBL318115 | 0.93 | F2 (0.81) | CD38DPP4F2EPHX2SLC28A3 | |
| Hydrochloric Acid SCHEMBL30438359 | 0.92 | CD38 (0.72) | CD38DPP4F2EGFRKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240263203-A1 | RECOMBINANT HOST CELLS WITH IMPROVED PRODUCTION OF TETRAKETIDE DERIVATIVES | IPTECTOR ASSETS APS (DK) | 2024-08-08 | — | — | US | claimed |
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | claimed |
| US-20220279829-A1 | Use of Anthocyanin-Anionic Polysaccharide Complex for Preventing or Treating Influenza Virus A Infection | JBKLAB CO., LTD. (KR) | 2022-09-08 | — | — | US | claimed |
| US-20220249675-A1 | Composition for Preventing, Ameliorating, or Treating Gastritis or peptic Ulcer Comprising Anthocyanin-Negatively Charged Polysaccharide Complex as Active Ingredient | JBKLAB CO., LTD. (KR) | 2022-08-11 | — | — | US | claimed |
| EP-3978025-A1 | COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING GASTRITIS OR PEPTIC ULCER COMPRISING ANTHOCYANIN-NEGATIVELY CHARGED POLYSACCHARIDE COMPLEX AS ACTIVE INGREDIENT | JBKLAB Co., Ltd. (KR) | 2022-04-06 | — | — | EP | claimed |
| EP-3978026-A1 | USE OF ANTHOCYANIN-ANIONIC POLYSACCHARIDE COMPLEX FOR PREVENTING OR TREATING INFLUENZA VIRUS A INFECTION | JBKLAB Co., Ltd. (KR) | 2022-04-06 | — | — | EP | claimed |
| CN-114040759-A | Composition for preventing, ameliorating or treating gastritis or peptic ulcer comprising anthocyanin-negatively charged polysaccharide complex as active ingredient | 株式会社张峰根硏究所 | 2022-02-11 | — | — | CN | claimed |
| CN-114025754-A | Use of anthocyanidin-anionic polysaccharide complex for preventing or treating influenza a virus infection | 株式会社张峰根硏究所 | 2022-02-08 | — | — | CN | claimed |
| CN-106794214-B | Composition containing a mixture of plant extracts or a mixture of molecules contained in said plants | 瓦尔比奥蒂斯公司 | 2021-06-15 | — | — | CN | claimed |
| CN-111973660-A | Composition containing a mixture of plant extracts or of molecules contained in said plants and uses thereof | 瓦尔比奥蒂斯公司 | 2020-11-24 | — | — | CN | claimed |
| EP-2096172-A2 | Genetic sequences having methyltransferase activity and uses therefor | International Flower Developments Proprietary Limited (AU) | 2009-09-02 | — | — | EP | claimed |
| US-20090176718-A1 | Berry Preparations For Treatment Of Diabetes And Metabolic Syndrome | NIH - DEITR | 2009-07-09 | — | — | US | claimed |
| WO-2009059218-A1 | BERRY PREPARATIONS FOR TREATMENT OF DIABETES AND METABOLIC SYNDROME | PHYTOMEDICS, INC. (US) | 2009-05-07 | — | — | WO | claimed |
| WO-2008016593-A2 | BIOACTIVE DEPSIDE AND ANTHOCYANIN COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2008-02-07 | — | — | WO | claimed |
| US-20070150984-A1 | Genetic sequences having methyltransferase activity and uses therefor | INTERNATIONAL FLOWER DEVELOPMENTS PTY.LTD. OF COLLINGWOOD (AU) | 2007-06-28 | — | — | US | claimed |
| EP-1478753-A4 | GENETIC SEQUENCES HAVING METHYLTRANSFERASE ACTIVITY AND USES THEREFOR | INTERNAT FLOWERS DEVELOPMENTS (AU) | 2007-03-28 | — | — | EP | claimed |
| US-6967032-B2 | Mixtures of anthracyanins, monosaccharides, disaccharides | MEDPALETT PHARMACEUTICALS AS (NO) | 2005-11-22 | — | — | US | claimed |
| EP-1478753-A1 | GENETIC SEQUENCES HAVING METHYLTRANSFERASE ACTIVITY AND USES THEREFOR | INTERNATIONAL FLOWER DEVELOPMENTS Pty. Ltd. (AU) | 2004-11-24 | — | — | EP | claimed |
| US-20040131749-A1 | Phytochemicals from edible bean process streams | ARCHER-DANIELS-MIDLAND COMPANY | 2004-07-08 | — | — | US | claimed |
| WO-2003062428-A1 | GENETIC SEQUENCES HAVING METHYLTRANSFERASE ACTIVITY AND USES THEREFOR | INTERNATIONAL FLOWER DEVELOPMENTS PTY LTD (AU) | 2003-07-31 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176718-A1 | Berry Preparations For Treatment Of Diabetes And Metabolic Syndrome | GPR119, FABP4, GYS2 | CD38 740/4885DPP4 109/4885F2 1393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.